Abstract
Summary: Increased leukocyte migration inhibition factor (LIF) production by coeliac patients' lymphocytes is a reliable immunologic test for gluten-sensitive coeliac disease providing the small peptide subfractions of gluten are used as mitogens. To investigate discrepancies in results obtained in various published studies, subfractions (B2 and B3) of crude gluten peptic tryptic digest (Frazer's fraction III (F3) were used singly and in combination as mitogens in coeliac patients and compared in various doses with F3. There was significant increased production of LIF with B2 or B3 when tested separately as compared to a mixture of B2 B3 or to F3. LIF production with B2 or B3 was 23.7 × 6.9%; with B2 + B3, it was 10.65 × 14.7% (t = 4.o5; P < 0.0005); and with F3, it was 9.2. × 10.2% (t = 5.8; P <0.0005). There was no difference in the response between B2 + B3 and F3 (t = 0.4; P = 0.32). Studies of LIF production following stimulation by various doses and combinations of gluten mitogens in the same patient gave the best results with B2 or B3 in μg doses, with a tendency to less LIF production with higher dosages or combinations of B2 + B3 or F3, even to abolition of LIF production in some coeliac cases. The LIF assay is a reliable immunologic test for gluten sensitivity, providing the B2 or B3 subfractions are used as mitogens.
Speculation: It is speculated that subfractioning of Frazer's fraction III of a peptic tryptic digest of gluten into smaller peptides which are used as mitogens allows for the detection of an increased number of immunogenic sites on mononuclear cells. When these small fractions, B2 and B3, are used as mitogens, lymphocytes from cases of coeliac disease produce increased amounts of leukocyte migration inhibition factor. Mixing these antigens diminishes leukocyte migration inhibition factor production, probably due to masking of antigenic sites.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ashkenazi, A., Levin, S., Idar, D. et al. Immunological Assay for the Diagnosis of Coeliac Disease: Interaction between Purified Gluten Fractions. Pediatr Res 14, 776–778 (1980). https://doi.org/10.1203/00006450-198005000-00013
Issue Date:
DOI: https://doi.org/10.1203/00006450-198005000-00013
Keywords
This article is cited by
-
The fluorescent immunosorbent test for IgG gliadin antibodies and the leucocyte migration inhibition test in coeliac disease; comparison of diagnostic value
European Journal of Pediatrics (1985)
-
Isolation of coeliac active peptide fractions from gliadin
Zeitschrift f�r Lebensmittel-Untersuchung und -Forschung (1983)
-
Toxicity of different wheat gliadins in coeliac disease
Zeitschrift f�r Lebensmittel-Untersuchung und -Forschung (1982)
-
Cellular immunity in children with coeliac disease
European Journal of Pediatrics (1982)